Cinacalcet, fetuin-A and interleukin-6

Nephrology Dialysis Transplantation

Volumn 23, Issue 4, 2008, Pages 1460-1461

  Marino, Angela ^a   Giotta, Nicola ^a  

^a Cardinal Massaja Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CARBONATE; CINACALCET; FETUIN A; INTERLEUKIN 6; OSTEOPROTEGERIN; SEVELAMER; VITAMIN D; ALPHA2HS GLYCOPROTEIN; NAPHTHALENE DERIVATIVE; PLASMA PROTEIN;

BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; HEMODIALYSIS; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; BLOOD; CHRONIC KIDNEY FAILURE; METABOLISM; NOTE; RENAL REPLACEMENT THERAPY; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME;

BLOOD PROTEINS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; NAPHTHALENES; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 42949110907     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm856     Document Type: Letter

References (5)

1. Messa P, Alberti L, Como G et al. Calcimimetic increases osteoprotegerin and decreases fetuin-A levels in dialysis patients. Nephrol Dial Transplant. 2007; 22: 2724-2725
2. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454
3. Cozzolino M, Galassi A, Biondi ML et al. Decreased serum fetuin-A levels after a single haemodialysis session. Nephrol Dial Transplant 2007; 22: 290-291
4. Ferramosca E, Burke S, Chasan-Taber S et al. Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. Am Heart J 2005; 149: 820-825
5. Timms PM, Mannan N, Hitman GA et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002; 95: 787-796